<- Go Home
NuVasive, Inc.
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery.
Market Cap
$2.1B
Volume
847.2K
Cash and Equivalents
$80.7M
EBITDA
$210.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$878.7M
Profit Margin
71.66%
52 Week High
$49.53
52 Week Low
$35.17
Dividend
N/A
Price / Book Value
2.34
Price / Earnings
72.95
Price / Tangible Book Value
24.74
Enterprise Value
$2.9B
Enterprise Value / EBITDA
12.82
Operating Income
$82.6M
Return on Equity
3.31%
Return on Assets
2.42
Cash and Short Term Investments
$80.7M
Debt
$907.9M
Equity
$892.5M
Revenue
$1.2B
Unlevered FCF
$4.9M
Sector
Health Care Equipment and Supplies
Category
N/A